Related Experiment Videos

Central venous access catheters

¹Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Surgical Oncology Clinics of North America

|July 1, 1995

Abstract:

Indwelling central venous access catheters were first introduced into clinical practice about 20 years ago. Today these catheters are an indispensable part of the treatment provided to adult and pediatric oncology patients. This article discusses the indications and major complications of central venous catheters.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.

European journal of cancer care·2015

Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo.

Breast cancer research and treatment·2011

Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.

European journal of cancer (Oxford, England : 1990)·2011

Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?

Breast cancer research and treatment·2008

Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC).

Annals of oncology : official journal of the European Society for Medical Oncology·2008

See all related articles